Industry/Technology: AI (Artificial Intelligence), MedTech
Region – Middle East
Founded: 2023
Technology: AI
Industry: MedTech, HeathTech
Value
- Objective and standardized assessment
- Real-time decision support
- Easier integration into workflows
- Lower treatment costs
- Increased screening capacity
- Scalable preventive care
Problem solving
Amplifai Health focuses on one of the most serious complications of diabetes — diabetic foot ulcers (DFUs), which are a leading cause of lower-limb amputations worldwide. Their flagship product TFscan uses thermal imaging and AI to detect abnormal heat patterns in the feet before visible symptoms appear, enabling early intervention.
Achievements
- Saudi FDA (SFDA) approval for TFscan — described as the world’s first SaMD for diabetic foot screening.
- Registration with the national procurement authority (NUPCO), enabling nationwide adoption in Saudi healthcare facilities.
- Publication of the largest global multicenter AI thermography study for diabetic foot risk detection (1,120 patients).
If you have a similar solution and are looking for funding opportunities, check out our catalog of international competitions.